Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
Publications
Publications
  • Article
  • npj Digital Medicine

Germany's Digital Health Reforms in the COVID-19 Era: Lessons and Opportunities for Other Countries

By: Sara Gerke, Ariel D. Stern and Timo Minssen
  • Format:Electronic
ShareBar

Abstract

Reimbursement is a key challenge for many new digital health solutions, whose importance and value have been highlighted and expanded by the current COVID-19 pandemic. Germany’s new Digital Healthcare Act (Digitale–Versorgung–Gesetz or DVG) entitles all individuals covered by statutory health insurance to reimbursement for certain digital health applications (i.e., insurers will pay for their use). Since Germany, like the United States (U.S.), is a multi-payer health care system, the new Act provides a particularly interesting case study for U.S. policymakers. We first provide an overview of the new German DVG and outline the landscape for reimbursement of digital health solutions in the U.S, including recent changes to policies governing telehealth during the COVID-19 pandemic. We then discuss challenges and unanswered questions raised by the DVG, ranging from the limited scope of the Act to privacy issues. Lastly, we highlight early lessons and opportunities for other countries.

Keywords

Covid-19; Reimbursement; Digital Health Reforms; Health Pandemics; Health Care and Treatment; Online Technology; Governing Rules, Regulations, and Reforms; Germany

Citation

Gerke, Sara, Ariel D. Stern, and Timo Minssen. "Germany's Digital Health Reforms in the COVID-19 Era: Lessons and Opportunities for Other Countries." Art. 94. npj Digital Medicine 3 (2020).
  • Read Now

About The Author

Ariel D. Stern

Technology and Operations Management
→More Publications

More from the Authors

    • April 15, 2021
    • New England Journal of Medicine

    Remote Patient Monitoring—Overdue or Overused?

    By: Keizra Mecklai, Nicholas Smith, Ariel Dora Stern and Daniel B. Kramer
    • March, 2021
    • npj Digital Medicine

    Ushering in Safe, Effective, Secure, and Ethical Medicine in the Digital Era

    By: William J. Gordon, Andrea Coravos and Ariel Dora Stern
    • January–February 2021
    • American Journal of Therapeutics

    Food and Drug Administration Guidance Documents and New Medical Devices: The Case of Breast Prostheses

    By: Rachel E. Weitzman, Ariel Dora Stern and Daniel B. Kramer
More from the Authors
  • Remote Patient Monitoring—Overdue or Overused? By: Keizra Mecklai, Nicholas Smith, Ariel Dora Stern and Daniel B. Kramer
  • Ushering in Safe, Effective, Secure, and Ethical Medicine in the Digital Era By: William J. Gordon, Andrea Coravos and Ariel Dora Stern
  • Food and Drug Administration Guidance Documents and New Medical Devices: The Case of Breast Prostheses By: Rachel E. Weitzman, Ariel Dora Stern and Daniel B. Kramer
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Digital Accessibility
Copyright © President & Fellows of Harvard College